LivaNova PLC (LIVN) officer details RSU vesting and updated share holdings

Rhea-AI Filing Summary

LivaNova PLC officer reports RSU vesting and share withholding for taxes. The President, Cardiopulmonary of LivaNova PLC reported the vesting and settlement of 967 restricted stock units into ordinary shares on 12/15/2025 at an exercise price of $0. On the same date, 416 ordinary shares were disposed of through share withholding at a price of $63.06 to satisfy tax liabilities related to the vesting.

After these transactions, the officer beneficially owns 8,850 ordinary shares directly and 219 ordinary shares indirectly through a spouse. The RSUs were originally granted on December 15, 2023 under the Amended and Restated LivaNova PLC 2022 Incentive Award Plan and vested over a two-year schedule ending December 15, 2025.

Insider Trade Summary

967 shares exercised/converted

Mixed 4 txns

Insider Poletti Franco

Role President, Cardiopulmonary

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	967	$0.00	--
Exercise	Ordinary Shares	967	$0.00	--
Tax Withholding	Ordinary Shares	416	$63.06	$26K
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Restricted Stock Units — 0 shares (Direct); Ordinary Shares — 9,266 shares (Direct); Ordinary Shares — 219 shares (Indirect, By Spouse)

Footnotes (1)

1. Reporting person had vested restricted stock units ("RSUs") settled in ordinary shares of LivaNova PLC (the "Company"), GBP 1.00 par value. Shares withheld to satisfy tax liability. Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Amended and Restated LivaNova PLC 2022 Incentive Award Plan (the "Plan") and the award agreement. On December 15, 2023, reporting person was granted RSUs subject to a two-year vesting schedule, the final vesting for which occurred on December 15, 2025. The RSUs were subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Poletti Franco

(Last) (First) (Middle)

20 EASTBOURNE TERRACE

(Street)

LONDON X0 W2 6LA

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LivaNova PLC [ LIVN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, Cardiopulmonary

3. Date of Earliest Transaction (Month/Day/Year)
12/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	12/15/2025		M		967	A	$0(1)	9,266	D
Ordinary Shares	12/15/2025		F		416(2)	D	$63.06	8,850	D
Ordinary Shares								219	I	By Spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(3)	12/15/2025		M			967	(4)	(4)	Ordinary Shares	967	$0	0	D

Explanation of Responses:

1. Reporting person had vested restricted stock units ("RSUs") settled in ordinary shares of LivaNova PLC (the "Company"), GBP 1.00 par value.

2. Shares withheld to satisfy tax liability.

3. Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Amended and Restated LivaNova PLC 2022 Incentive Award Plan (the "Plan") and the award agreement.

4. On December 15, 2023, reporting person was granted RSUs subject to a two-year vesting schedule, the final vesting for which occurred on December 15, 2025. The RSUs were subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

Remarks:

	/s/ Sarah K. Mohr, Attorney-in-Fact	12/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did LivaNova PLC (LIVN) report in this Form 4?

The President, Cardiopulmonary of LivaNova PLC reported the vesting of 967 restricted stock units into ordinary shares on 12/15/2025, along with a related share withholding for taxes.

How many LivaNova PLC (LIVN) shares vested and at what price?

A total of 967 restricted stock units vested into ordinary shares of LivaNova PLC at an exercise price of $0 per share, as these RSUs settled in ordinary shares.

How many LivaNova PLC (LIVN) shares were withheld for taxes and at what value?

416 ordinary shares of LivaNova PLC were disposed of through withholding to satisfy tax liabilities at a price of $63.06 per share.

What is the LivaNova PLC (LIVN) insider’s share ownership after the reported transaction?

Following the transactions, the reporting officer beneficially owns 8,850 ordinary shares directly and 219 ordinary shares indirectly through a spouse.

When were the LivaNova PLC (LIVN) RSUs originally granted and how did they vest?

The RSUs were granted on December 15, 2023 under the Amended and Restated LivaNova PLC 2022 Incentive Award Plan and were subject to a two-year vesting schedule, with final vesting on December 15, 2025.

What does each LivaNova PLC (LIVN) RSU represent in this filing?

Each restricted stock unit represents a contingent right to receive one ordinary share of LivaNova PLC, in accordance with the terms of the company’s 2022 Incentive Award Plan and the award agreement.